ME Therapeutics Holding (XCNQ:METX) Operating Cash Flow per Share : C$-0.03 (TTM As of Feb. 2024)

View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Operating Cash Flow per Share?

ME Therapeutics Holding's operating cash flow per share for the three months ended in Feb. 2024 was C$-0.00. ME Therapeutics Holding's operating cash flow per share for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for ME Therapeutics Holding's Operating Cash Flow per Share or its related term are showing as below:

XCNQ:METX's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.3
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

ME Therapeutics Holding Operating Cash Flow per Share Historical Data

The historical data trend for ME Therapeutics Holding's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Operating Cash Flow per Share Chart

ME Therapeutics Holding Annual Data

Trend

Aug22

Aug23

Operating Cash Flow per Share

-0.01

ME Therapeutics Holding Quarterly Data
	Aug22	Dec22	May23	Aug23	Nov23	Feb24
Operating Cash Flow per Share	Get a 7-Day Free Trial			-	-0.01	-	-0.01	-

Competitive Comparison of ME Therapeutics Holding's Operating Cash Flow per Share

For the Biotechnology subindustry, ME Therapeutics Holding's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ME Therapeutics Holding's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's Price-to-Operating-Cash-Flow falls into.

ME Therapeutics Holding Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

ME Therapeutics Holding's Operating Cash Flow per Share for the fiscal year that ended in Aug. 2023 is calculated as

Operating Cash Flow per Share (A: Aug. 2023 )	=	Cash Flow from Operations (A: Aug. 2023 )	/	Shares Outstanding (Diluted Average) (A: Aug. 2023 )
	=	-0.303	/	23.561
	=	-0.01

ME Therapeutics Holding's Operating Cash Flow per Share for the quarter that ended in Aug. 2023 is calculated as

Operating Cash Flow per Share (Q: Feb. 2024 )	=	Cash Flow from Operations (Q: Feb. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Feb. 2024 )
	=	-0.099	/	23.589
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.03

ME Therapeutics Holding Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

Q9T:Germany

Address

177 Robson Street, Vancouver, BC, CAN, V6B 0N3

Website

https://www.metherapeutics.com

ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines